A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Condition: Breast Cancer Interventions: Drug: ARV-471; Drug: Anastrozole; Procedure: Surgical resection of breast tumor Sponsors: Arvinas Inc.; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials